ISPOR Patient Representative Travel Grant

The candidate for the Patient Travel Grant must:

• Represent a nonprofit, voluntary health agency [501(c)3 in the US] with a mission to:
  • Combat a particular disease, disability, or group of diseases/disabilities or
  • Improve and protect the health of a particular group of people
• Engage in programs, such as, research, education, advocacy, and service to individuals and communities
• Able to provide patient perspectives relevant to health policy, health technology assessment, and/or research and development (ie clinical trials, therapy development, etc.)
• NOT be employed by health technology producers (biopharmaceutical, medical device, or diagnostic companies)

View Upcoming Conferences

Submit your application here.

The recipient of the ISPOR Travel Grant receives complimentary registration to the conference and a fixed-amount travel reimbursement, per the ISPOR Travel Reimbursement Policy. 

• Jaymee Maaghop, Gastrointestinal Society, Canada
• Alisa Casavant, Arthritis Foundation, United States
• Ysabel Duron, The Latino Cancer Institute, United States
• Camilla Tajzler, Canadian Kidney Cancer information system (CKCis), McGill University, Canada
• Paige Nues, International Rett Syndrome Foundation, United States
• Lara Bloom, The Ehlers-Danlos Society, United States
• Tina Aswani-Omprakash, South Asian IBD Alliance, United States
• Tiffany Westrich-Robertson, AiArthritis (International Foundation for Autoimmune & Autoinflammatory Arthritis), United States
• Patil Mksyartinian, Colorectal Cancer Canada, Canada

• Bettina Ryll – Melanoma Patient Network Europe, Sweden
• Derick Mitchell - Irish Platform for Patient Organisations, Science & Industry (IPPOSI), Ireland
• Finn McCartney - The European Patients’ Academy on Therapeutic Innovation (EUPATI), Netherlands
• Lotte Klim – Denmark
• Marzena Nelken - Krajowe Forum Orphan, Poland
• Mirjana Babamova - FEMINA M, Association for Help and Support of Patients with Gynecological Diseases, Macedonia
• Nabin Paudel - Retina International, Ireland
• Petra Adámková - ONKO Unie/Cancer Patients Voice, Czech Republic
• Sabrina Hanna - The Cancer Collaborative, Canada
• Sara Rossi - European Patient Advocacy Institute (EPAI), Italy
• Silke Schoch - National Health Council, United States
• Sybelle Drumond - ACAMRJ, Brazil

• Ryan Fischer, Foundation for Angelman Syndrome Therapeutics (FAST), United States
• Kate Avery, Beyond Celiac, United States
• Olufunke Akiyode, Shout Global Health, United States
• Ella Balasa, Patient Advocate  , United States
• Tiffany Westrich-Robertson, AiArthritis (International Foundation Autoimmune & Autoinflammatory Arthritis), United States
• Kimberly Richardson, Black Cancer Collaborative, United States
• Ushma Patel, Patient Advocate, United States
• Stephanie Steele, Immune Deficiency Foundatino, United States
• Gail Attara, Gastrointestinal Society, Canada
• Alma Robles Avila, Guatemalan Association of Heroes of Hope for Cancer Patients, Guatemala
• Angie Botto-van Bemden, Musculoskeletal Research International, United States
• Veronica Stasiak Bednarczuk de Oliveira, Unidos pela Vida - Brazilian Institute of Cystic Fibrosis Care, Brazil
• Marjorie Morrison, Lymphoma Coalition, Canada
• Jason Harris, National Psoriasis Foundation, United States
• Kevin Wake, Uriel E. Owens Sickle Cell Disease Association of the Midwest, United States

• Omar A. Escontrias, National Health Council, United States
  
• Birgitta Termander, Rare Diseases Sweden, Sweden
  
• Stavros Terzakis, Union of Heart Patients of Navy Officers, Coast Guard and Friends, Hellenic Navy, Greece
  
• Ana-Ecaterina Amariutei, European Patient Advocacy Institute, Germany 
  
• Richard Ballerand, European Institute for Innovation and Technology, United Kingdom
  
• Jennifer Camaradou, Health ClusterNET, Netherlands 
• Marjorie Morrison, Lymphoma Coalition, Canada 

• Lisa Machado, Canadian CML Network, Canada
  
• Sneha Dave, Generation Patient, United States
  
• Jason Harris, National Psoriasis Foundation, United States
  
• Ashley Valentine, Sick Cells, United States
  
• Kevin Wake, Uriel E. Owens Sickle Cell Disease Association of the Midwest, United States
  
• Anna Hyde, Arthritis Foundation, United States

• Valentina Strammiello, European Patients Forum, Belgium
  
• Stefan Živković, National Organisation for Rare Diseases of Serbia, Serbia
  
• Ananda Plate, Myeloma Patients Europe, Germany
  
• Tina Mesarič, University of Maribor, Slovenia
  
• Merce Cases, European Patient Advocacy Institute, Germany
  
• Sara Pérez Martínez, Freelance Patient Advocate, Spain
  
• Laura Gumbert, SMA Europe, Bayreuth, Germany
  
• Sara Loud, Accelerated Cure Project, Inc., United States
  
• Veronica del Gragnano Stasiak Bednarczuk de Oliveira, Unidos pela Vida-Brazilian Institute of Cystic Fibrosis Care, Brazil
  
• Anne-Pierre Pickaert, Care 4 Access, France
  
• Angie Botto-van Bemden, Musculoskeletal Research International Patient Advocate, United States
  
• Karla Ruiz de Castilla, Esperantra, Peru